{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:26:01Z","timestamp":1793913961235,"version":"4.8.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2023,7,3]]},"DOI":"10.1080\/14712598.2023.2221784","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T13:58:23Z","timestamp":1685800703000},"page":"589-593","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?"],"prefix":"10.1080","volume":"23","author":[{"given":"Sheila A","family":"Doggrell","sequence":"first","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Gold Coast Campus, Griffith University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213558"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024277"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020977300"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01887-2018"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0242-x"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11435-x"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01347-2022"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.03.011"},{"key":"cit0009","unstructured":"ClinicalTrials.gov. A long-term follow-up study of sotatercept for PAH treatment (MK-7962-004); SOTERIA. [cited 2023 Apr 26]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04796337?term=sotatercept&draw=2&rank=1"},{"key":"cit0010","unstructured":"ClinialTrials.gov. A study of sotatercept in participants with PAH WHO FC III or FC IV at high risk of mortality (MK-7962-006\/ZENITH); ZENITH. [cited 2023 Apr 26]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04896008?term=sotatercept&draw=2&rank=2"},{"key":"cit0011","unstructured":"ClinialTrials.gov. Study of sotatercept in newly diagnosed intermediate- and high-risk PAH participants (MK-7962-005\/A011-13); HYPERION. [cited 2023 Mar 21]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04811092?term=sotatercept&draw=2&rank=7"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.575"},{"key":"cit0013","unstructured":"ClinialTrials.gov. Study to evaluate sotatercept (MK-7962) in children with pulmonary arterial hypertension (PAH) (MK-7962-008); [cited 2023 Apr 26]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05587712?term=sotatercept&draw=3&rank=19"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1064290"},{"key":"cit0015","unstructured":"ClinialTrials.gov. A study of sotatercept for the treatment of Cpc-PH due to HFpEF (MK-7962-007\/A011-16); CADENCE. [cited 2023 Mar 21]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04945460?term=sotatercept&draw=2&rank=4"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12212"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2023.2221784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T16:09:46Z","timestamp":1689869386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2023.2221784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"alternative-id":["10.1080\/14712598.2023.2221784"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2023.2221784","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}